scispace - formally typeset
J

Juan Domínguez-Robles

Researcher at Queen's University Belfast

Publications -  51
Citations -  2524

Juan Domínguez-Robles is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Drug delivery & Lignin. The author has an hindex of 21, co-authored 50 publications receiving 1297 citations. Previous affiliations of Juan Domínguez-Robles include University of Córdoba (Spain).

Papers
More filters
Journal ArticleDOI

Implantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications

TL;DR: An overview of classification of these drug delivery devices; the mechanism of drug release; the materials used for manufacture; the various methods of manufacture; and examples of clinical applications of implantable drug Delivery devices are given.
Journal ArticleDOI

Antioxidant pla composites containing lignin for 3D printing applications: A potential material for healthcare applications

TL;DR: PLA/LIG were used to design meshes with different designs for wound dressing purposes and it was observed that the dimensions of the meshes affected the permeation rate of CUR, which could be modified according to the patient’s needs.
Journal ArticleDOI

Synthesis and Characterization of Lignin Hydrogels for Potential Applications as Drug Eluting Antimicrobial Coatings for Medical Materials.

TL;DR: A simple method to prepare lignin-based hydrogels is described, which demonstrated logarithmic reductions in adherence of Staphylococcus aureus and Proteus mirabilis of up to 5.0 relative to the commonly employed medical material poly(vinyl chloride) (PVC).
Journal ArticleDOI

Aqueous acetone fractionation of kraft, organosolv and soda lignins.

TL;DR: The results illustrate that the proposed aqueous acetone fractionation protocol could indeed produce pure and uniform lignin fraction and it was applicable for lignins from different sources.
Journal ArticleDOI

Cellulose Nanofibers and Other Biopolymers for Biomedical Applications. A Review

TL;DR: The future clinical applications of biopolymers are vast, due to their inherent biocompatibility, biodegradability and low immunogenicity, which their synthetic counterparts do not share.